IBDEI0TX ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,13464,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13464,1,3,0)
;;=3^Convergence Excess
;;^UTILITY(U,$J,358.3,13464,1,4,0)
;;=4^H51.12
;;^UTILITY(U,$J,358.3,13464,2)
;;=^5006252
;;^UTILITY(U,$J,358.3,13465,0)
;;=H51.11^^51^637^18
;;^UTILITY(U,$J,358.3,13465,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13465,1,3,0)
;;=3^Convergence Insufficiency
;;^UTILITY(U,$J,358.3,13465,1,4,0)
;;=4^H51.11
;;^UTILITY(U,$J,358.3,13465,2)
;;=^5006251
;;^UTILITY(U,$J,358.3,13466,0)
;;=H47.612^^51^637^19
;;^UTILITY(U,$J,358.3,13466,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13466,1,3,0)
;;=3^Cortical Blindness,Left Side of Brain
;;^UTILITY(U,$J,358.3,13466,1,4,0)
;;=4^H47.612
;;^UTILITY(U,$J,358.3,13466,2)
;;=^5006167
;;^UTILITY(U,$J,358.3,13467,0)
;;=H47.611^^51^637^20
;;^UTILITY(U,$J,358.3,13467,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13467,1,3,0)
;;=3^Cortical Blindness,Right Side of Brain
;;^UTILITY(U,$J,358.3,13467,1,4,0)
;;=4^H47.611
;;^UTILITY(U,$J,358.3,13467,2)
;;=^5006166
;;^UTILITY(U,$J,358.3,13468,0)
;;=H53.2^^51^637^21
;;^UTILITY(U,$J,358.3,13468,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13468,1,3,0)
;;=3^Diplopia
;;^UTILITY(U,$J,358.3,13468,1,4,0)
;;=4^H53.2
;;^UTILITY(U,$J,358.3,13468,2)
;;=^35208
;;^UTILITY(U,$J,358.3,13469,0)
;;=H47.642^^51^637^22
;;^UTILITY(U,$J,358.3,13469,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13469,1,3,0)
;;=3^Disord of Visual Cortex in Vasc Disord,Left Side of Brain
;;^UTILITY(U,$J,358.3,13469,1,4,0)
;;=4^H47.642
;;^UTILITY(U,$J,358.3,13469,2)
;;=^5006176
;;^UTILITY(U,$J,358.3,13470,0)
;;=H47.641^^51^637^23
;;^UTILITY(U,$J,358.3,13470,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13470,1,3,0)
;;=3^Disord of Visual Cortex in Vasc Disord,Right Side of Brain
;;^UTILITY(U,$J,358.3,13470,1,4,0)
;;=4^H47.641
;;^UTILITY(U,$J,358.3,13470,2)
;;=^5006175
;;^UTILITY(U,$J,358.3,13471,0)
;;=H50.51^^51^637^24
;;^UTILITY(U,$J,358.3,13471,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13471,1,3,0)
;;=3^EP Esophoria
;;^UTILITY(U,$J,358.3,13471,1,4,0)
;;=4^H50.51
;;^UTILITY(U,$J,358.3,13471,2)
;;=^265435
;;^UTILITY(U,$J,358.3,13472,0)
;;=H50.00^^51^637^25
;;^UTILITY(U,$J,358.3,13472,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13472,1,3,0)
;;=3^ET Esotropia,Unspec
;;^UTILITY(U,$J,358.3,13472,1,4,0)
;;=4^H50.00
;;^UTILITY(U,$J,358.3,13472,2)
;;=^5006208
;;^UTILITY(U,$J,358.3,13473,0)
;;=G51.4^^51^637^26
;;^UTILITY(U,$J,358.3,13473,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13473,1,3,0)
;;=3^Facial Myokymia
;;^UTILITY(U,$J,358.3,13473,1,4,0)
;;=4^G51.4
;;^UTILITY(U,$J,358.3,13473,2)
;;=^5003996
;;^UTILITY(U,$J,358.3,13474,0)
;;=M31.6^^51^637^27
;;^UTILITY(U,$J,358.3,13474,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13474,1,3,0)
;;=3^Giant Cell Arteritis NEC
;;^UTILITY(U,$J,358.3,13474,1,4,0)
;;=4^M31.6
;;^UTILITY(U,$J,358.3,13474,2)
;;=^5011748
;;^UTILITY(U,$J,358.3,13475,0)
;;=H53.47^^51^637^29
;;^UTILITY(U,$J,358.3,13475,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13475,1,3,0)
;;=3^Heteronymous Bilateral Field Defects
;;^UTILITY(U,$J,358.3,13475,1,4,0)
;;=4^H53.47
;;^UTILITY(U,$J,358.3,13475,2)
;;=^268847
;;^UTILITY(U,$J,358.3,13476,0)
;;=H50.50^^51^637^30
;;^UTILITY(U,$J,358.3,13476,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13476,1,3,0)
;;=3^Heterophoria
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0TX 3748 printed Sep 23, 2025@19:31:41 Page 2
IBDEI0TX ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,13464,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,13464,1,3,0)
+4 ;;=3^Convergence Excess
+5 ;;^UTILITY(U,$J,358.3,13464,1,4,0)
+6 ;;=4^H51.12
+7 ;;^UTILITY(U,$J,358.3,13464,2)
+8 ;;=^5006252
+9 ;;^UTILITY(U,$J,358.3,13465,0)
+10 ;;=H51.11^^51^637^18
+11 ;;^UTILITY(U,$J,358.3,13465,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,13465,1,3,0)
+14 ;;=3^Convergence Insufficiency
+15 ;;^UTILITY(U,$J,358.3,13465,1,4,0)
+16 ;;=4^H51.11
+17 ;;^UTILITY(U,$J,358.3,13465,2)
+18 ;;=^5006251
+19 ;;^UTILITY(U,$J,358.3,13466,0)
+20 ;;=H47.612^^51^637^19
+21 ;;^UTILITY(U,$J,358.3,13466,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,13466,1,3,0)
+24 ;;=3^Cortical Blindness,Left Side of Brain
+25 ;;^UTILITY(U,$J,358.3,13466,1,4,0)
+26 ;;=4^H47.612
+27 ;;^UTILITY(U,$J,358.3,13466,2)
+28 ;;=^5006167
+29 ;;^UTILITY(U,$J,358.3,13467,0)
+30 ;;=H47.611^^51^637^20
+31 ;;^UTILITY(U,$J,358.3,13467,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,13467,1,3,0)
+34 ;;=3^Cortical Blindness,Right Side of Brain
+35 ;;^UTILITY(U,$J,358.3,13467,1,4,0)
+36 ;;=4^H47.611
+37 ;;^UTILITY(U,$J,358.3,13467,2)
+38 ;;=^5006166
+39 ;;^UTILITY(U,$J,358.3,13468,0)
+40 ;;=H53.2^^51^637^21
+41 ;;^UTILITY(U,$J,358.3,13468,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,13468,1,3,0)
+44 ;;=3^Diplopia
+45 ;;^UTILITY(U,$J,358.3,13468,1,4,0)
+46 ;;=4^H53.2
+47 ;;^UTILITY(U,$J,358.3,13468,2)
+48 ;;=^35208
+49 ;;^UTILITY(U,$J,358.3,13469,0)
+50 ;;=H47.642^^51^637^22
+51 ;;^UTILITY(U,$J,358.3,13469,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,13469,1,3,0)
+54 ;;=3^Disord of Visual Cortex in Vasc Disord,Left Side of Brain
+55 ;;^UTILITY(U,$J,358.3,13469,1,4,0)
+56 ;;=4^H47.642
+57 ;;^UTILITY(U,$J,358.3,13469,2)
+58 ;;=^5006176
+59 ;;^UTILITY(U,$J,358.3,13470,0)
+60 ;;=H47.641^^51^637^23
+61 ;;^UTILITY(U,$J,358.3,13470,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,13470,1,3,0)
+64 ;;=3^Disord of Visual Cortex in Vasc Disord,Right Side of Brain
+65 ;;^UTILITY(U,$J,358.3,13470,1,4,0)
+66 ;;=4^H47.641
+67 ;;^UTILITY(U,$J,358.3,13470,2)
+68 ;;=^5006175
+69 ;;^UTILITY(U,$J,358.3,13471,0)
+70 ;;=H50.51^^51^637^24
+71 ;;^UTILITY(U,$J,358.3,13471,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,13471,1,3,0)
+74 ;;=3^EP Esophoria
+75 ;;^UTILITY(U,$J,358.3,13471,1,4,0)
+76 ;;=4^H50.51
+77 ;;^UTILITY(U,$J,358.3,13471,2)
+78 ;;=^265435
+79 ;;^UTILITY(U,$J,358.3,13472,0)
+80 ;;=H50.00^^51^637^25
+81 ;;^UTILITY(U,$J,358.3,13472,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,13472,1,3,0)
+84 ;;=3^ET Esotropia,Unspec
+85 ;;^UTILITY(U,$J,358.3,13472,1,4,0)
+86 ;;=4^H50.00
+87 ;;^UTILITY(U,$J,358.3,13472,2)
+88 ;;=^5006208
+89 ;;^UTILITY(U,$J,358.3,13473,0)
+90 ;;=G51.4^^51^637^26
+91 ;;^UTILITY(U,$J,358.3,13473,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,13473,1,3,0)
+94 ;;=3^Facial Myokymia
+95 ;;^UTILITY(U,$J,358.3,13473,1,4,0)
+96 ;;=4^G51.4
+97 ;;^UTILITY(U,$J,358.3,13473,2)
+98 ;;=^5003996
+99 ;;^UTILITY(U,$J,358.3,13474,0)
+100 ;;=M31.6^^51^637^27
+101 ;;^UTILITY(U,$J,358.3,13474,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,13474,1,3,0)
+104 ;;=3^Giant Cell Arteritis NEC
+105 ;;^UTILITY(U,$J,358.3,13474,1,4,0)
+106 ;;=4^M31.6
+107 ;;^UTILITY(U,$J,358.3,13474,2)
+108 ;;=^5011748
+109 ;;^UTILITY(U,$J,358.3,13475,0)
+110 ;;=H53.47^^51^637^29
+111 ;;^UTILITY(U,$J,358.3,13475,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,13475,1,3,0)
+114 ;;=3^Heteronymous Bilateral Field Defects
+115 ;;^UTILITY(U,$J,358.3,13475,1,4,0)
+116 ;;=4^H53.47
+117 ;;^UTILITY(U,$J,358.3,13475,2)
+118 ;;=^268847
+119 ;;^UTILITY(U,$J,358.3,13476,0)
+120 ;;=H50.50^^51^637^30
+121 ;;^UTILITY(U,$J,358.3,13476,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,13476,1,3,0)
+124 ;;=3^Heterophoria
